Cases & Deals

  • Home
  • Practices
  • Capella Therapeutics builds patent portfolios for pre-clinical pharmaceutical candidates for use in cancer treatment and other diseases

Share

Capella Therapeutics builds patent portfolios for pre-clinical pharmaceutical candidates for use in cancer treatment and other diseases

July 2020

Client(s) Capella Therapeutics, Inc.

On behalf of Capella Therapeutics, Inc., Jones Day built and prosecuted global patent portfolios covering small molecule, pre-clinical pharmaceutical candidates for use in treating proliferative diseases, including cancer.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.